Pulmonary, cardiac, and thyroid involvement in disseminated Pseudallescheria boydii

S. H. De Ment, R. R L Smith, Judith Karp, W. G. Merz

Research output: Contribution to journalArticle

Abstract

The present case and the previous case descriptions of disseminated pseudallescheriasis are very similar in clinical presentation and organ involvement to disseminated aspergillosis. In addition, the hyphae of the two organisms are exceedingly difficult to differentiate in tissue sections, with the only distinguishable morphologic features being the presence of characteristic conidiophores and terminal conidia in P boydii. Most importantly, however, is the fact that, despite the numerous clinical and morphologic similarities of P boydii and Aspergillus, the two organisms respond quite differently to antifungal therapy. Pseudoallescheria boydii isolates are frequently resistant to amphotericin B in viro, with an MIC above attainable blood levels, and are susceptible to miconazole, as was the isolate obtained from this patient. Therefore, the empiric use of amphotericin B for clinical findings suggestive of invasive aspergillosis, as in this patient, may not afford an adequate therapeutic coverage. Rapid differentiation between Aspergillus species and P boydii can be difficult. Currently, culture of involved tissues is the only means for securing a specific diagnosis. This may require invasive procedures and several days of incubation time. An alternative solution may be the empiric combined use of amphotericin B and miconazole. However, the information concerning the combined effects of these two agents remains unclear as there is conflicting in vitro evidence that suggests both additive or synergic effects as well as antagonism.

Original languageEnglish (US)
Pages (from-to)859-861
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume108
Issue number11
StatePublished - 1984

Fingerprint

Pseudallescheria
Amphotericin B
Miconazole
Thyroid Gland
Aspergillosis
Aspergillus
Lung
Fungal Spores
Hyphae
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Pulmonary, cardiac, and thyroid involvement in disseminated Pseudallescheria boydii. / De Ment, S. H.; Smith, R. R L; Karp, Judith; Merz, W. G.

In: Archives of Pathology and Laboratory Medicine, Vol. 108, No. 11, 1984, p. 859-861.

Research output: Contribution to journalArticle

@article{9bc9eda21a8c47b684ab6973628d28bb,
title = "Pulmonary, cardiac, and thyroid involvement in disseminated Pseudallescheria boydii",
abstract = "The present case and the previous case descriptions of disseminated pseudallescheriasis are very similar in clinical presentation and organ involvement to disseminated aspergillosis. In addition, the hyphae of the two organisms are exceedingly difficult to differentiate in tissue sections, with the only distinguishable morphologic features being the presence of characteristic conidiophores and terminal conidia in P boydii. Most importantly, however, is the fact that, despite the numerous clinical and morphologic similarities of P boydii and Aspergillus, the two organisms respond quite differently to antifungal therapy. Pseudoallescheria boydii isolates are frequently resistant to amphotericin B in viro, with an MIC above attainable blood levels, and are susceptible to miconazole, as was the isolate obtained from this patient. Therefore, the empiric use of amphotericin B for clinical findings suggestive of invasive aspergillosis, as in this patient, may not afford an adequate therapeutic coverage. Rapid differentiation between Aspergillus species and P boydii can be difficult. Currently, culture of involved tissues is the only means for securing a specific diagnosis. This may require invasive procedures and several days of incubation time. An alternative solution may be the empiric combined use of amphotericin B and miconazole. However, the information concerning the combined effects of these two agents remains unclear as there is conflicting in vitro evidence that suggests both additive or synergic effects as well as antagonism.",
author = "{De Ment}, {S. H.} and Smith, {R. R L} and Judith Karp and Merz, {W. G.}",
year = "1984",
language = "English (US)",
volume = "108",
pages = "859--861",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - Pulmonary, cardiac, and thyroid involvement in disseminated Pseudallescheria boydii

AU - De Ment, S. H.

AU - Smith, R. R L

AU - Karp, Judith

AU - Merz, W. G.

PY - 1984

Y1 - 1984

N2 - The present case and the previous case descriptions of disseminated pseudallescheriasis are very similar in clinical presentation and organ involvement to disseminated aspergillosis. In addition, the hyphae of the two organisms are exceedingly difficult to differentiate in tissue sections, with the only distinguishable morphologic features being the presence of characteristic conidiophores and terminal conidia in P boydii. Most importantly, however, is the fact that, despite the numerous clinical and morphologic similarities of P boydii and Aspergillus, the two organisms respond quite differently to antifungal therapy. Pseudoallescheria boydii isolates are frequently resistant to amphotericin B in viro, with an MIC above attainable blood levels, and are susceptible to miconazole, as was the isolate obtained from this patient. Therefore, the empiric use of amphotericin B for clinical findings suggestive of invasive aspergillosis, as in this patient, may not afford an adequate therapeutic coverage. Rapid differentiation between Aspergillus species and P boydii can be difficult. Currently, culture of involved tissues is the only means for securing a specific diagnosis. This may require invasive procedures and several days of incubation time. An alternative solution may be the empiric combined use of amphotericin B and miconazole. However, the information concerning the combined effects of these two agents remains unclear as there is conflicting in vitro evidence that suggests both additive or synergic effects as well as antagonism.

AB - The present case and the previous case descriptions of disseminated pseudallescheriasis are very similar in clinical presentation and organ involvement to disseminated aspergillosis. In addition, the hyphae of the two organisms are exceedingly difficult to differentiate in tissue sections, with the only distinguishable morphologic features being the presence of characteristic conidiophores and terminal conidia in P boydii. Most importantly, however, is the fact that, despite the numerous clinical and morphologic similarities of P boydii and Aspergillus, the two organisms respond quite differently to antifungal therapy. Pseudoallescheria boydii isolates are frequently resistant to amphotericin B in viro, with an MIC above attainable blood levels, and are susceptible to miconazole, as was the isolate obtained from this patient. Therefore, the empiric use of amphotericin B for clinical findings suggestive of invasive aspergillosis, as in this patient, may not afford an adequate therapeutic coverage. Rapid differentiation between Aspergillus species and P boydii can be difficult. Currently, culture of involved tissues is the only means for securing a specific diagnosis. This may require invasive procedures and several days of incubation time. An alternative solution may be the empiric combined use of amphotericin B and miconazole. However, the information concerning the combined effects of these two agents remains unclear as there is conflicting in vitro evidence that suggests both additive or synergic effects as well as antagonism.

UR - http://www.scopus.com/inward/record.url?scp=0021714217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021714217&partnerID=8YFLogxK

M3 - Article

C2 - 6548359

AN - SCOPUS:0021714217

VL - 108

SP - 859

EP - 861

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -